In this study, we investigated the interaction and synergetic bioavailability of Strawberry DNA, with CUR and aspirin (non-steroid anti-inflammatory drugs). The goal was to establish evidence that there is some impact on adding curcumin in DNA and to study its viscous effects, due its availability and usage as high viscosity therapeutic (HV) drugs, which is in demand in pharmaceutical industries. The goal of this experiment was to see if curcumin has similar effects so that it can be used in the pharma industry. If they have similar results in viscosity, then curcumin could be used in drugs to make them more natural and have anti-inflammatory properties. From the preliminary results, it can be concluded that curcumin is a possible viscosity and a therapeutic enhancer, and it may also have similar effects with Aspirin. This could be a novel approach to deliver the therapeutic effectiveness of CUR in strawberry DNA for better absorption.
|State||Published - Oct 10 2020|
|Event||American Chemical Society - Midland MI|
Duration: Oct 10 2020 → Oct 10 2020
|Conference||American Chemical Society|
|Period||10/10/20 → 10/10/20|